Literature DB >> 6268704

Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique.

D Kozbor, J C Roder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268704

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  34 in total

1.  Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro.

Authors:  M A Marín; G Fontán; M López-Trascasa
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  Factor(s) required by EBV transformed lymphocytes to grow under limiting dilution conditions.

Authors:  C Negri; R Chiesa; G C Ricotti
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

Review 3.  Development trends for human monoclonal antibody therapeutics.

Authors:  Aaron L Nelson; Eugen Dhimolea; Janice M Reichert
Journal:  Nat Rev Drug Discov       Date:  2010-09-03       Impact factor: 84.694

Review 4.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

5.  Human monoclonal antibody. Construction of stable clones reactive with human breast cancer.

Authors:  A J Strelkauskas; C L Taylor
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.

Authors:  M Matsuda; M Kamei; N Sugimoto; Y Ma; S Hashizume
Journal:  Eur J Epidemiol       Date:  1992-01       Impact factor: 8.082

7.  Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.

Authors:  R F Tiebout; R W Sauerwein; W G van der Meer; F van Boxtel-Oosterhof; W P Zeijlemaker
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

8.  Characterization of human hybridomas secreting antibody to tetanus toxoid.

Authors:  J W Larrick; K E Truitt; A A Raubitschek; G Senyk; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 9.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

10.  Monoclonal antibody against a lactose epitope of glycosphingolipids binds to melanoma tumour cells.

Authors:  K Ding; T Ekberg; J Zeuthen; S Teneberg; K A Karlsson; A Rosén
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.